Recent Company News

• 09:21 PM ET Feb 24, 2026
  

  NICE recommends Genentech's Avastin (and biosimilars) with fluoropyrimidine-based chemotherapy to treat metastatic colorectal cancer (CHF 374.00, 0.00)

• 04:34 PM ET Feb 23, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:57 AM ET Feb 24, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:04 AM ET Feb 23, 2026
  

  StreetAccount Consensus Metrics Preview - Fresenius Q4 Earnings (€52.18, +0.12)

• 08:01 PM ET Feb 20, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 03:53 AM ET Feb 19, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (123 total)

• 09:09 AM ET Feb 09, 2026
  

  Fresenius Kabi and Phlow Corp. (private) announce U.S. manufacturing collaboration for epinephrine (8:00ET) (€49.55, -0.21)

• 09:37 AM ET Feb 05, 2026
  

  Erste Group upgrades LIN; downgrades AEM, BAC, FRE.GR; others (13:45 CET/07:45 ET)

• 08:02 AM ET Jan 14, 2026
  

  Fresenius signs strategic development agreement with TQ Therapeutics to support the scalable and efficient manufacturing of cell and gene therapies (€51.58, +0.34)